These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 39049565)

  • 21. Inter-alpha-trypsin inhibitor heavy chain H4 as a diagnostic and prognostic indicator in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Noh CK; Kim SS; Kim DK; Lee HY; Cho HJ; Yoon SY; Lee GH; Hyun SA; Kim YJ; Kim HJ; Hwang JA; Ahn SJ; Shin SJ; Lee KM; Yoo BM; Cho SW; Cheong JY
    Clin Biochem; 2014 Sep; 47(13-14):1257-61. PubMed ID: 24836184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotype may correlate with liver carcinogenesis and tumor characteristics in cirrhotic patients infected with hepatitis B virus subtype adw.
    Tsubota A; Arase Y; Ren F; Tanaka H; Ikeda K; Kumada H
    J Med Virol; 2001 Oct; 65(2):257-65. PubMed ID: 11536231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis B virus DNA in peripheral blood leukocytes. A comparison between hepatocellular carcinoma and other hepatitis B virus-related chronic liver diseases.
    Leung NW; Tam JS; Lau GT; Leung TW; Lau WY; Li AK
    Cancer; 1994 Feb; 73(4):1143-8. PubMed ID: 8313316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High level of serum Cripto-1 in hepatocellular carcinoma, especially with hepatitis B virus infection.
    Zhang Y; Xu H; Chi X; Fan Y; Shi Y; Niu J
    Medicine (Baltimore); 2018 Aug; 97(35):e11781. PubMed ID: 30170372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of impact of serial hepatitis B virus DNA levels on development of hepatocellular carcinoma.
    Chan HL; Wong VW; Wong GL; Chim AM; Lai LH; Sung JJ
    J Clin Microbiol; 2009 Jun; 47(6):1830-6. PubMed ID: 19386857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis B virus-related hepatocellular carcinogenesis and its prevention.
    Ikeda K; Arase Y; Kobayashi M; Someya T; Hosaka T; Saitoh S; Sezaki H; Akuta N; Suzuki F; Suzuki Y; Kumada H
    Intervirology; 2005; 48(1):29-38. PubMed ID: 15785087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Conservation and variability of hepatitis B core at different chronic hepatitis stages.
    Yll M; Cortese MF; Guerrero-Murillo M; Orriols G; Gregori J; Casillas R; González C; Sopena S; Godoy C; Vila M; Tabernero D; Quer J; Rando A; Lopez-Martinez R; Esteban R; Riveiro-Barciela M; Buti M; Rodríguez-Frías F
    World J Gastroenterol; 2020 May; 26(20):2584-2598. PubMed ID: 32523313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level.
    Chen CJ; Yang HI; Su J; Jen CL; You SL; Lu SN; Huang GT; Iloeje UH;
    JAMA; 2006 Jan; 295(1):65-73. PubMed ID: 16391218
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis of Untreated Minimally Active Chronic Hepatitis B Patients in Comparison With Virological Responders by Antivirals.
    Lee HW; Kim SU; Park JY; Baatarkhuu O; Kim DY; Ahn SH; Han KH; Kim BK
    Clin Transl Gastroenterol; 2019 Jun; 10(6):e00036. PubMed ID: 31107725
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antiviral therapy predicts the outcomes following resection of hepatocellular carcinoma in patients negative for HBV DNA: a propensity score matching analysis.
    Xu M; Zhou Z; Xu R; Zhang H; Lin N; Zhong Y
    World J Surg Oncol; 2019 Mar; 17(1):45. PubMed ID: 30823932
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Connective tissue growth factor (CTGF/CCN2) in serum is an indicator of fibrogenic progression and malignant transformation in patients with chronic hepatitis B infection.
    Gressner OA; Fang M; Li H; Lu LG; Gressner AM; Gao CF
    Clin Chim Acta; 2013 Jun; 421():126-31. PubMed ID: 23501329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL.
    Lee HW; Park SY; Lee YR; Lee H; Lee JS; Kim SU; Park JY; Kim DY; Ahn SH; Kim BK
    Am J Gastroenterol; 2022 Feb; 117(2):288-294. PubMed ID: 34506308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occult hepatitis B infection and HBV replicative activity in patients with cryptogenic cause of hepatocellular carcinoma.
    Wong DK; Huang FY; Lai CL; Poon RT; Seto WK; Fung J; Hung IF; Yuen MF
    Hepatology; 2011 Sep; 54(3):829-36. PubMed ID: 21809355
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatitis B virus subgenotype A1 predominates in liver disease patients from Kerala, India.
    Gopalakrishnan D; Keyter M; Shenoy KT; Leena KB; Thayumanavan L; Thomas V; Vinayakumar K; Panackel C; Korah AT; Nair R; Kramvis A
    World J Gastroenterol; 2013 Dec; 19(48):9294-306. PubMed ID: 24409056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatocellular carcinoma risk in chronic hepatitis B virus-infected compensated cirrhosis patients with low viral load.
    Sinn DH; Lee J; Goo J; Kim K; Gwak GY; Paik YH; Choi MS; Lee JH; Koh KC; Yoo BC; Paik SW
    Hepatology; 2015 Sep; 62(3):694-701. PubMed ID: 25963803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined use of murine double minute-2 promoter methylation and serum AFP improves diagnostic efficiency in hepatitis B virus-related hepatocellular carcinoma.
    Wang JW; Qian Y; Wu CS; Zhao NH; Fang Y; Yuan XD; Gao S; Fan YC; Wang K
    Int J Med Sci; 2020; 17(18):3190-3199. PubMed ID: 33173438
    [No Abstract]   [Full Text] [Related]  

  • 37. Heavy alcohol consumption increases the incidence of hepatocellular carcinoma in hepatitis B virus-related cirrhosis.
    Lin CW; Lin CC; Mo LR; Chang CY; Perng DS; Hsu CC; Lo GH; Chen YS; Yen YC; Hu JT; Yu ML; Lee PH; Lin JT; Yang SS
    J Hepatol; 2013 Apr; 58(4):730-5. PubMed ID: 23220252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term effect of lamivudine treatment on the incidence of hepatocellular carcinoma in patients with hepatitis B virus infection.
    Kurokawa M; Hiramatsu N; Oze T; Yakushijin T; Miyazaki M; Hosui A; Miyagi T; Yoshida Y; Ishida H; Tatsumi T; Kiso S; Kanto T; Kasahara A; Iio S; Doi Y; Yamada A; Oshita M; Kaneko A; Mochizuki K; Hagiwara H; Mita E; Ito T; Inui Y; Katayama K; Yoshihara H; Imai Y; Hayashi E; Hayashi N; Takehara T
    J Gastroenterol; 2012 May; 47(5):577-85. PubMed ID: 22231575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver Cirrhosis, Not Antiviral Therapy, Predicts Clinical Outcome in Cohorts with Heterogeneous Hepatitis B Viral Status.
    Kim MN; Hwang SG; Kim BK; Park JY; Kim DY; Han KH; Kim SU; Ahn SH
    Gut Liver; 2019 Mar; 13(2):197-205. PubMed ID: 30602075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
    El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
    Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.